Shares of U.S. optical networking companies jumped before the opening bell on Tuesday, November 17, 2026, after Reuters reported that the Trump administration plans to press ahead with efforts to block imports of Chinese data center equipment. The measure targets new models of Chinese optical transceivers, the parts that move data over fiber-optic cables inside data centers.

Lobbying Didn't Stop It, According to Three People

Want to apply this to your own portfolio?Open OptionsPilot →

Reuters first reported in August that the Federal Communications Commission was seeking the ban on national security grounds (Reuters, Aug. 4). Tuesday's report added that:

  • Amazon, Google, Meta, CoreWeave and Cisco joined Microsoft in a meeting with White House officials earlier this year to push back, and executives said U.S. firms could need up to a decade to comply.
  • Three additional people said the measure is moving forward anyway.
  • No date for a final rule was reported (24/7 Wall St.).
  • The FCC and the large tech companies didn't respond to Reuters' requests for comment, and Microsoft declined to comment.
  • Two-Thirds of the Supply Is Chinese. Who Fills the Gap?

    Per Reuters, citing Counterpoint Research, China holds about two-thirds of the global optical transceiver market, led by firms such as Eoptolink and Zhongji Innolight. A Foundation for American Innovation report cited by Reuters said U.S.-based Coherent and Lumentum compete with them but lack the scale to replace Chinese vendors. One person told Reuters the U.S. firms raised the risk that China could retaliate by banning exports of indium phosphide, a material needed to make transceivers.

    That is the tension the market is trading: a ban could shift orders toward U.S. suppliers, but capacity limits, input-material risk and the long compliance timeline all cut against a quick windfall.

    The Opening Pop Faded Within 25 Minutes

    The early headlines didn't hold. ChartMill had Coherent up 8.82% to $221.37 premarket, and CNBC cited an 11% gain. Cboe's delayed quotes tell the story from there:

    | Stock | Prior close | Open | Session high | Last (approx. 9:45 to 9:52 a.m. ET) | Coherent (COHR)$203.43$215.02$217.20$208.73 (+2.6%) Lumentum (LITE)$546.00$566.66$575.46$562.91 (+3.1%) | Applied Optoelectronics (AAOI) | $45.16 | $48.17 | $48.22 | $46.60 (+3.2%) |

    All three stocks came into the day well below where they were a month ago after the AI-hardware selloff. Per ChartMill, COHR and LITE fell 6.75% and 8.48% on Monday. Tuesday's bounce, at least early on, made back only part of Monday's drop.

    IV30 Barely Moved

    A policy headline that changes the long-term picture for an industry can still leave near-term option pricing alone. On Cboe's data, 30-day implied volatility (IV30) was roughly flat:

  • COHR: IV30 about 92.3, up 0.5 point
  • LITE: IV30 about 91.4, up 0.1 point
  • AAOI: IV30 about 115.3, up 0.3 point
  • Those are already high levels. The Nov 20 weeklies are richer still, with near-the-money implied volatility of about 125% to 165%. Part of that likely reflects Nvidia's earnings report after Tuesday's close, a key event for AI-hardware names. Using midpoints of the delayed quotes, the Nov 20 at-the-money straddles were priced at about:

  • COHR $207.50 straddle: about $22.80, or roughly 10.9% of the share price (wide markets: call $11.30 / $16.00, put $6.80 / $11.50)
  • LITE $565 straddle: about $55.35, or roughly 9.8%
  • AAOI $46.50 straddle: about $5.83, or roughly 12.5%
  • Our arithmetic, not a forecast: Tuesday's move so far is a fraction of what the weeklies price for the full three days.

    Early Flow Leaned to Calls, Against Put-Heavy Open Interest

    In the first minutes of trading, calls outnumbered puts by more than 2-to-1 in all three names. That's early-session volume, so the totals are small:

    | Stock | Call volume | Put volume | Call OI | Put OI | COHR~1,700~780~162,400~210,300 LITE~2,900~1,160~152,100~168,700 | AAOI | ~2,230 | ~1,030 | ~263,100 | ~197,600 |

    The busiest lines were mostly out-of-the-money weeklies: the COHR Nov 20 $215 calls (about 265 contracts), the LITE Nov 20 $625 calls (about 360) and the AAOI Nov 20 $52 calls (about 310). Standing open interest in COHR and LITE still leaned toward puts, a sign of hedges or bearish positions built during the selloff. Volume alone doesn't show whether contracts were bought or sold.

    When the Next Headline Could Come From Washington or Beijing

  • No rule yet. The report is based on unnamed sources and no final-rule date was given. A delay, a narrower rule or a reversal could hit these stocks as fast as Tuesday's report lifted them.
  • Retaliation risk. An indium phosphide export ban, the risk the tech firms raised, could squeeze the same U.S. suppliers that would benefit from a ban.
  • Nvidia tonight. AI-hardware names can gap after Nvidia's results regardless of trade policy. Short premium through the report is exposed to that gap.
  • Wide markets. Some COHR weekly quotes were more than $4 wide. Limit orders matter.
  • Defined risk. Spreads cap losses. Uncovered short options in names with IV near 100% can lose far more than the premium collected.
  • For background, see our implied volatility explainer and the OCC options disclosure document.

    Sources

  • Reuters via Investing.com: Trump's China data center curb advances despite Amazon, Google, Meta lobbying
  • Reuters: Trump administration drafting ban on Chinese data center devices (Aug. 4, 2026)
  • Investing.com: Coherent, Lumentum jump as US presses ahead with China equipment curbs
  • 24/7 Wall St.: Coherent jumps 8%, Applied Optoelectronics climbs 7%
  • CNBC: Stocks moving the most today
  • ChartMill: S&P 500 premarket movers on Nov. 17
  • Cboe delayed options quotes: COHR, LITE, AAOI
  • OCC: Characteristics and Risks of Standardized Options
  • *By the OptionsPilot Editorial Team. Published November 17, 2026, 7:30 AM PT. Market data are 15-minute-delayed Cboe quotes from early in Tuesday's session and will change. This article is for education only and is not investment advice. Options involve risk and are not suitable for all investors.*